Holding(s) in Company

Advanced Medical Solutions Grp PLC
16 April 2008


For immediate release                                              16 April 2008


                      Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')

                               Holding in Company

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical 
technology company, received notification on 15 April 2008 from Mr J D Slater and 
family that following recent share purchases they are interested in 7,175,000 
ordinary shares of 5 pence each in the Company, representing 5.013 per cent of the 
Company's issued share capital.


For further information, please contact:

Advanced Medical Solutions Group plc

Don Evans, Chief Executive Officer

Mary Tavener, Finance Director                    Tel: [phone]

www.admedsol.com

Buchanan Communications                           Tel: [phone]

Mark Court, Mary-Jane Johnson, Stasa

Filipic
                                                  
Landsbanki Securities (UK) Ltd                    Tel: [phone]

Shaun Dobson / Claes Spang


Notes to Editors:


Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.


Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the
design, development and manufacture of innovative and technologically advanced
products for woundcare and other medical applications.


In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS' resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move a product from design and development through to production and delivery
ready for distribution into customer markets.


The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing topical wounds sold direct to hospitals or through
distributors.


AMS's technology and products currently serve the majority of the key global
markets and strategic partners.



                     This information is provided by RNS
            The company news service from the London Stock Exchange